# Brit Mollenhauer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/brit-mollenhauer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,078 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 93 |
| i10-index | 281 |
| Last Known Institution | University of Kassel |
| OpenAlex ID | https://openalex.org/A5082185657 |
| ORCID iD | https://orcid.org/0000-0001-8437-3645 |
| Works | 473 |

## Researcher papers

Showing 12 of 19.

- [Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines](https://scholariq.org/papers/diagnostic-criteria-for-mild-cognitive-impairment-in-parkinson-s-disease-i/)
- [Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria](https://scholariq.org/papers/clinical-diagnosis-of-progressive-supranuclear-palsy-the-movement-disorder/)
- [The Parkinson Progression Marker Initiative (PPMI)](https://scholariq.org/papers/the-parkinson-progression-marker-initiative-ppmi/)
- [Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study](https://scholariq.org/papers/risk-and-predictors-of-dementia-and-parkinsonism-in-idiopathic-rem-sleep/)
- [A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease](https://scholariq.org/papers/a-mutation-in-vps35-encoding-a-subunit-of-the-retromer-complex-causes-late-onset/)
- [Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study](https://scholariq.org/papers/assessment-of-heterogeneity-among-participants-in-the-parkinson-s-progression/)
- [The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort](https://scholariq.org/papers/the-parkinson-s-progression-markers-initiative-ppmi-establishing-a-pd-biomarker/)
- [A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research](https://scholariq.org/papers/a-biological-definition-of-neuronal-synuclein-disease-towards-an-integrated/)
- [A Practical Guide to Immunoassay Method Validation](https://scholariq.org/papers/a-practical-guide-to-immunoassay-method-validation/)
- [Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry](https://scholariq.org/papers/cerebrospinal-fluid-and-blood-biomarkers-for-neurodegenerative-dementias-an/)
- [Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort](https://scholariq.org/papers/longitudinal-change-of-clinical-and-biological-measures-in-early-parkinson-s/)
- [Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression](https://scholariq.org/papers/validation-of-serum-neurofilament-light-chain-as-a-biomarker-of-parkinson-s/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)

## Researcher university

- [University of Kassel](https://scholariq.org/institutions/university-of-kassel/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.